Pregnant and lactating women face significant barriers to participation in clinical trials due to gender biases, underinvestment, and regulatory hurdles. A review by Bohren et al. identifies factors like trust in medical systems, therapeutic optimism, and equipoise as facilitators. Strategies to address barriers include education, training, and environmental restructuring. The study aims to improve access to medicines for women during pregnancy and postpartum by understanding and addressing these issues.